Literature DB >> 14514581

Diabetes and idiopathic cardiomyopathy: a nationwide case-control study.

Alain G Bertoni1, Arthur Tsai, Edward K Kasper, Frederick L Brancati.   

Abstract

OBJECTIVE: Controversy exists regarding the relation between diabetes and nonischemic idiopathic cardiomyopathy (ICM), and only limited data on the incidence of ICM in adults with diabetes are available. Therefore, we used the 1995 Nationwide Inpatient Sample (NIS) to determine discharge rates and test the hypothesis that diabetes is independently associated with ICM. RESEARCH DESIGN AND METHODS: The 1995 NIS includes demographic and diagnostic data on all discharges from >900 representative hospitals in 19 states. ICD-9 codes were used to identify ICM, defined as discharges with a diagnosis of primary cardiomyopathy but without established risk factors for cardiomyopathy. Control subjects were selected by stratified random sampling by age to yield 10 per ICM case. The analyzed covariates included age, race, median income, diabetes, and hypertension. Multivariate logistic regression was used to conduct case-control analyses.
RESULTS: Using sampling weights, we estimated that in 1995, the rate of hospital discharge for ICM among individuals diagnosed with diabetes was 7.6 per 1000. The prevalence of diabetes was substantially higher in the 44837 ICM vs. 450254 control subjects (26.6 vs. 17.2%), corresponding to a relative odds (RO) of 1.75 (95% CI 1.71-1.79). After adjusting for age, sex, race, hypertension, and median income using multiple logistic regression, diabetes remained significantly associated with ICM (RO 1.58, 95% CI 1.55-1.62).
CONCLUSIONS: We concluded that diabetes is independently associated with ICM in the general U.S. population.

Entities:  

Mesh:

Year:  2003        PMID: 14514581     DOI: 10.2337/diacare.26.10.2791

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  56 in total

1.  [Aerobic and strength training in patients with diabetes mellitus type 2 and heart failure].

Authors:  D Niederseer; J Niebauer
Journal:  Herz       Date:  2012-08       Impact factor: 1.443

2.  PPARα agonist prevented the apoptosis induced by glucose and fatty acid in neonatal cardiomyocytes.

Authors:  W Q Nan; T Q Shan; X Qian; W Ping; G A Bing; L L Ying
Journal:  J Endocrinol Invest       Date:  2010-03-30       Impact factor: 4.256

3.  Role of Bcl-2/adenovirus E1B 19 kDa-interacting protein 3 in myocardial cells in diabetes.

Authors:  Wenzhong Zhou; Jian Yang; D I Zhang; Fengyin Li; Guo Li; Yanyun Gu; Min Luo
Journal:  Exp Ther Med       Date:  2015-04-22       Impact factor: 2.447

4.  Abnormal glucose and lipid control in non-ischemic left ventricular dysfunction.

Authors:  Danilo Neglia; Tiziana Sampietro; Cecilia Vecoli; Riccardo Liga; Giuseppe Rossi; Elena Filidei; Federico Bigazzi; Patricia Iozzo; Daniela Giannessi; Antonio L'Abbate; Daniele Rovai
Journal:  J Nucl Cardiol       Date:  2012-08-10       Impact factor: 5.952

Review 5.  Is diabetic cardiomyopathy a specific entity?

Authors:  Mitja Letonja; Danijel Petrovič
Journal:  World J Cardiol       Date:  2014-01-26

Review 6.  Standard and etiology-directed evidence-based therapies in myocarditis: state of the art and future perspectives.

Authors:  Bernhard Maisch; Sabine Pankuweit
Journal:  Heart Fail Rev       Date:  2013-11       Impact factor: 4.214

7.  Dietary pattern, the metabolic syndrome, and left ventricular mass and systolic function: the Multi-Ethnic Study of Atherosclerosis.

Authors:  Longjian Liu; Jennifer A Nettleton; Alain G Bertoni; David A Bluemke; João A Lima; Moyses Szklo
Journal:  Am J Clin Nutr       Date:  2009-06-10       Impact factor: 7.045

8.  Metformin in Diabetic Patients with Heart Failure: Safe and Effective?

Authors:  Ijeoma Ananaba Ekeruo; Amirreza Solhpour; Heinrich Taegtmeyer
Journal:  Curr Cardiovasc Risk Rep       Date:  2013-12-01

9.  Impairment of insulin-stimulated Akt/GLUT4 signaling is associated with cardiac contractile dysfunction and aggravates I/R injury in STZ-diabetic rats.

Authors:  Jiung-Pang Huang; Shiang-Suo Huang; Jen-Ying Deng; Li-Man Hung
Journal:  J Biomed Sci       Date:  2009-08-25       Impact factor: 8.410

Review 10.  Diabetic cardiomyopathy.

Authors:  Omar Asghar; Ahmed Al-Sunni; Kaivan Khavandi; Ali Khavandi; Sarah Withers; Adam Greenstein; Anthony M Heagerty; Rayaz A Malik
Journal:  Clin Sci (Lond)       Date:  2009-05       Impact factor: 6.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.